London Health Sciences Centre, University & Victoria Hospitals
London, Ontario, N6A 5A5, Canada
NCT Number: NCT01955330
OBJECTIVES:
The objectives of the year study are two-fold:
1. To determine the 5-7 year patency rate (rate of open bypass grafts) of the LITA graft and stent of patients who have already had robotically-assisted Hybrid CABG surgery using CTA and MPS-MIBI. 2. To determine patient quality of life at 5-7 years after robotically-assisted Hybrid CABG surgery
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
London, Ontario, N6A 5A5, Canada
New techniques such as robotically-assisted Hybrid CABG surgery need proper evaluation to ensure potential benefits gained are not harmful to that which we know to be of significant benefit to the patients, that being the left internal thoracic artery (LITA) graft (one of the main coronary arteries supplying your heart with blood). We are therefore proposing a 5-7 year CT-Angiography (CTA) and Myocardial Perfusion Scintigraphy (MPS-MIBI) to assess the patency rate of the LITA graft and the stented graft in patients that have already undergone robotically assisted Hybrid CABG.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lita to LAD performed by robot, Hybrid stent to other diseased coronary artery
Other names: Robotic Hybrid CABG
Time frame: 5-7 years post Hybrid surgery
To assess the graft patency of the LITA to LAD performed by the robot and the patency of the Stent.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
Long Term Follow-up of Robotic Hybrid Surgical Revascularization With CT Angiography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details